Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Augmedix Inc.

    NASDAQ: AUGX · Real-Time Price · USD
    2.35
    0.00 (0.00%)
    At close: Oct 01, 2024, 7:57 PM

    Augmedix Statistics

    Share Statistics

    Augmedix has 49.43M shares outstanding. The number of shares has increased by 0.94% in one year.

    Shares Outstanding

    n/a
    		 49.43M

    Shares Change (YoY)

    n/a
    		 0.94%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 67.45%

    Shares Floating

    n/a
    		 24.99M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,416

    FTD / Avg. Volume

    n/a
    		 0.18%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -13.41 and the forward PE ratio is null. Augmedix's PEG ratio is 0.35.

    PE Ratio

    n/a
    		 -13.41

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.73

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 11.02

    P/FCF Ratio

    n/a
    		 -13.86

    PEG Ratio

    n/a
    		 0.35
    Financial Ratio History

    Enterprise Valuation

    Augmedix has an Enterprise Value (EV) of 236.59M.

    EV / Sales

    n/a
    		 5.27

    EV / EBITDA

    n/a
    		 -13.38

    EV / EBIT

    n/a
    		 -15.32

    EV / FCF

    n/a
    		 -12.76

    Financial Position

    The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.93.

    Current Ratio

    n/a
    		 2.41

    Quick Ratio

    n/a
    		 2.41

    Debt / Equity

    n/a
    		 0.93

    Debt / EBITDA

    n/a
    		 -1.46

    Debt / FCF

    n/a
    		 -1.39

    Interest Coverage

    n/a
    		 -8.34

    Financial Efficiency

    Return on Equity is -82.2% and Return on Invested Capital is -41.94%.

    Return on Equity

    n/a
    		 -82.2%

    Return on Assets

    n/a
    		 -28.74%

    Return on Invested Capital

    n/a
    		 -41.94%

    Revenue Per Employee

    n/a
    		 $31,367.13

    Profits Per Employee

    n/a
    		 $-13,406.29

    Employee Count

    n/a
    		 1,430

    Asset Turnover

    n/a
    		 0.67

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 145K

    Effective Tax Rate

    n/a
    		 -0.76%

    Stock Price Statistics

    The stock price has increased by -17.54% in the last 52 weeks. The beta is -0.19, so Augmedix's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.19

    52-Week Price Change

    n/a
    		 -17.54%

    50-Day Moving Average

    n/a
    		 2.3

    200-Day Moving Average

    n/a
    		 2.97

    Relative Strength Index (RSI)

    n/a
    		 74.06

    Average Volume (20 Days)

    n/a
    		 808,771

    Income Statement

    In the last 12 months, Augmedix had revenue of 44.85M and earned -19.17M in profits. Earnings per share was -0.44.

    Revenue

    n/a
    		 44.85M

    Gross Profit

    n/a
    		 21.53M

    Operating Income

    n/a
    		 -18.78M

    Net Income

    n/a
    		 -19.17M

    EBITDA

    n/a
    		 -17.68M

    EBIT

    n/a
    		 -16.77M

    Earnings Per Share (EPS)

    n/a
    		 -0.44
    Full Income Statement

    Balance Sheet

    The company has 46.34M in cash and 25.85M in debt, giving a net cash position of 20.5M.

    Cash & Cash Equivalents

    n/a
    		 46.34M

    Total Debt

    n/a
    		 25.85M

    Net Cash

    n/a
    		 20.5M

    Retained Earnings

    n/a
    		 -144.96M

    Total Assets

    n/a
    		 53.67M

    Working Capital

    n/a
    		 15.93M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.44M and capital expenditures -3.1M, giving a free cash flow of -18.55M.

    Operating Cash Flow

    n/a
    		 -15.44M

    Capital Expenditures

    n/a
    		 -3.1M

    Free Cash Flow

    n/a
    		 -18.55M

    FCF Per Share

    n/a
    		 -0.42
    Full Cash Flow Statement

    Margins

    Gross margin is 47.99%, with operating and profit margins of -41.87% and -42.74%.

    Gross Margin

    n/a
    		 47.99%

    Operating Margin

    n/a
    		 -41.87%

    Pretax Margin

    n/a
    		 -42.42%

    Profit Margin

    n/a
    		 -42.74%

    EBITDA Margin

    n/a
    		 -39.42%

    EBIT Margin

    n/a
    		 -41.87%

    FCF Margin

    n/a
    		 -41.35%

    Dividends & Yields

    AUGX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -7.46%

    FCF Yield

    n/a
    		 -7.21%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AUGX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.62

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist